Keyphrases
Benzodiazepines
100%
Patients with Schizophrenia
70%
Schizophrenia Symptoms
59%
Placebo
53%
Bipolar Disorder
52%
Antipsychotics
49%
Benzodiazepine Withdrawal
49%
Melatonin
46%
All-cause Mortality
42%
Register Study
39%
Confidence Interval
29%
Anterior Cingulate Cortex
26%
Randomized Clinical Trial
26%
Population-wide
26%
Glutamate
26%
Prolonged-release Melatonin
24%
Add-on Treatment
24%
Control Subjects
23%
Antidepressants
21%
Benzodiazepine Dependence
18%
Denmark
17%
Second-generation Antipsychotics
17%
Psychosocial Functioning
17%
Healthy Volunteers
16%
Epithelial Ovarian Cancer
16%
Schizophrenia Diagnosis
15%
First-episode Psychosis
15%
Polysomnography
15%
Schizophrenia
15%
Randomized Controlled Trial
15%
Sleep Disturbance
15%
Pharmacology, Toxicology and Pharmaceutical Science
Benzodiazepine
58%
Melatonin
52%
Placebo
52%
Bipolar Disorder
39%
Antipsychotic
39%
Polypharmacy
33%
Case-Control Study
28%
Psychotropic Agent
26%
Ovary Cancer
26%
Randomized Clinical Trial
26%
All Cause Mortality
20%
Neuroscience
Benzodiazepine
62%
Antipsychotic
49%
Placebo
40%
Bipolar Disorder
39%
Melatonin
39%
Anterior Cingulate Cortex
26%
Glutamic Acid
26%
Psychoactive Drug
17%
Negative Syndrome
16%
Polysomnography
15%